Dexcom (DXCM)

Cost of Revenue

$478.40M

Quarterly · Period ending: · USD

DXCM logo

DXCM Cost of Revenue

Latest reported$478.40M
DXCM Quarterly Cost of Revenue ($0.00 → $478.40M)
High-resolution chart · PNG

DXCM cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
478,400,000
441,600,000
466,900,000
477,900,000
468,300,000
447,000,000
457,700,000
400,400,000
377,600,000
359,100,000
377,900,000
351,700,000
324,900,000
278,900,000
273,900,000
275,400,000
246,700,000
230,700,000
225,600,000
203,300,000
178,000,000
161,100,000
169,800,000
160,500,000
167,700,000
148,600,000
153,500,000
149,400,000
129,900,000
111,700,000
115,200,000
98,100,000
88,900,000
65,500,000
67,500,000
57,600,000
53,100,000
48,200,000
54,500,000
47,500,000
51,800,000
41,100,000
39,600,000
30,500,000
27,200,000
26,300,000
24,900,000
21,800,000
18,900,000
17,300,000
17,600,000
15,300,000
13,900,000
13,100,000
15,698,000
14,687,000
12,207,000
10,708,000
11,728,000
10,090,000
9,546,000
9,058,000
8,647,000
8,188,000
7,267,000
6,086,000
6,364,000
6,394,000
7,799,000
5,475,000
4,891,000
3,840,000
3,393,000
3,242,000
3,655,000
3,113,000
2,906,000
3,062,000
3,398,514
3,388,675
2,090,544
2,081,220
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.